← FDA DRUG APPROVALS

FDA ANDA · ANDA079232

LAX-LYTE WITH FLAVOR PACKS

Sponsor: L PERRIGO CO

APPLICATION
ANDA079232
TYPE
ANDA
ORIGINAL APPROVAL
2010-02-25
LATEST ACTION
2015-12-03
ROUTE
ORAL
DOSAGE FORM
FOR SOLUTION
MARKETING STATUS
Discontinued

Products

LAX-LYTE WITH FLAVOR PACKSDiscontinued
POLYETHYLENE GLYCOL 3350 420GM/BOT, POTASSIUM CHLORIDE 1.48GM/BOT, SODIUM BICARBONATE 5.72GM/BOT, SODIUM CHLORIDE 11.2GM/BOT · FOR SOLUTION · ORAL

Approval history

2015-12-03Labeling · Supplement 2 · standardAP
2010-02-25OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →